Off-label use of orphan medicinal products: a Belgian qualitative study.
Marc DoomsDavid CassimanSteven R A SimoensPublished in: Orphanet journal of rare diseases (2016)
While there is support from physicians and reimbursement experts, there is also concern in case of off-label use, mainly for reasons of patient safety especially when medicinal products are prescribed off-label in the absence of medical or scientific justification and driven by cost-containment motives.